CANCER PROGRESSION: IMMUNOHISTOCHEMICAL STUDY OF SURVIVIN AND XIAP IN NORMAL AND PATHOLOGICAL (BENIGN HYPERPLASTIC AND CANCER) HUMAN PROSTATE

被引:0
|
作者
Fraile, B. [1 ]
Chaves, C. [1 ]
Rodriguez-Berruguete, Gonzalo [1 ]
Nunez, C. [1 ]
Martinez-Onsurbe, P. [2 ]
Olmedilla, G. [2 ]
Bethecourt, F. [3 ]
Cansino, R. [3 ]
Paniagua, R. [3 ]
Royuela, M. [1 ]
机构
[1] Univ Alcala de Henares, Dept Cell Biol & Genet, Alcala De Henares 99775, Spain
[2] Principe Asturias Hosp, Dept Pathol, Alcala De Henares, Spain
[3] Hosp La Paz, Dept Urol, Madrid, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
206
引用
收藏
页码:3283 / 3284
页数:2
相关论文
共 50 条
  • [41] INHIBIN (10.7 KD PROSTATIC PEPTIDE) IN NORMAL, HYPERPLASTIC, AND MALIGNANT HUMAN ENDOMETRIA - AN IMMUNOHISTOCHEMICAL STUDY
    TENI, TR
    SAMPAT, MB
    SHETH, NA
    JOURNAL OF PATHOLOGY, 1992, 168 (01): : 35 - 40
  • [42] Involvement of human papillomavirus infections in prostate cancer progression
    Al Moustafa, Ala-Eddin
    MEDICAL HYPOTHESES, 2008, 71 (02) : 209 - 211
  • [43] Immunohistochemical Identification of Cancer Stem Cells in Human Prostate Carcinomas
    Yin, M.
    Mays, J.
    Falls, R.
    MODERN PATHOLOGY, 2012, 25 : 253A - 253A
  • [44] Immunohistochemical Identification of Cancer Stem Cells in Human Prostate Carcinomas
    Yin, M.
    Mays, J.
    Falls, R.
    LABORATORY INVESTIGATION, 2012, 92 : 253A - 253A
  • [45] Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue?
    Khair, AA
    Pacelli, A
    Iczkowski, KA
    Cheng, L
    Corica, FA
    Larson, TR
    Corica, A
    Bostwick, DG
    UROLOGY, 1999, 54 (01) : 67 - 72
  • [46] Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
    Stuchbery, Ryan
    Macintyre, Geoff
    Cmero, Marek
    Harewood, Laurence M.
    Peters, Justin S.
    Costello, Anthony J.
    Hovens, Christopher M.
    Corcoran, Niall M.
    ONCOTARGET, 2016, 7 (21) : 31384 - 31392
  • [47] Immunohistochemical finding of α-1-antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancer
    Tanaka, M
    Suzuki, Y
    Takaoka, K
    Murakami, S
    Suzuki, N
    Shimazaki, J
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (12) : 600 - 606
  • [48] Racial differences in the risk of benign prostatic hyperplasia (BPH) progression and prostate cancer
    Roehrborn, CG
    Logie, JW
    Blackman, N
    Brown, RR
    Lamerato, LE
    Hoke, GP
    JOURNAL OF UROLOGY, 2004, 171 (04): : 408 - 408
  • [49] Pathological validation of MRSI accuracy: Application to human prostate cancer
    Ma, HY
    Sing, NW
    Hua, TC
    Hoon, TP
    Herry, H
    Christopher, C
    CARS 2005: Computer Assisted Radiology and Surgery, 2005, 1281 : 1333 - 1333
  • [50] Immunohistochemical localization of interleukin-1 beta in benign prostatic hyperplasia and prostate cancer
    Zarnescu, O.
    Badea, P.
    Petrescu, A.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 336 - 336